JP2011513410A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011513410A5 JP2011513410A5 JP2010549729A JP2010549729A JP2011513410A5 JP 2011513410 A5 JP2011513410 A5 JP 2011513410A5 JP 2010549729 A JP2010549729 A JP 2010549729A JP 2010549729 A JP2010549729 A JP 2010549729A JP 2011513410 A5 JP2011513410 A5 JP 2011513410A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- aryl
- independently
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 6
- 125000001188 haloalkyl group Chemical group 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000002619 bicyclic group Chemical group 0.000 claims 3
- 125000002950 monocyclic group Chemical group 0.000 claims 3
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000005418 aryl aryl group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- -1 nitro, cyano, amino, hydroxy Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3387708P | 2008-03-05 | 2008-03-05 | |
US61/033,877 | 2008-03-05 | ||
PCT/US2009/035111 WO2009111239A2 (en) | 2008-03-05 | 2009-02-25 | Pyrrolidine derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011513410A JP2011513410A (ja) | 2011-04-28 |
JP2011513410A5 true JP2011513410A5 (US07846941-20101207-C00217.png) | 2012-04-12 |
JP5586484B2 JP5586484B2 (ja) | 2014-09-10 |
Family
ID=41054296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010549729A Active JP5586484B2 (ja) | 2008-03-05 | 2009-02-25 | ピロリジン誘導体 |
Country Status (16)
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2911655A1 (en) | 2012-10-24 | 2015-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tpl2 kinase inhibitors for preventing or treating diabetes and for promoting -cell survival |
KR102323049B1 (ko) | 2014-03-10 | 2021-11-05 | 마리 케이 인코포레이티드 | 피부 라이트닝 조성물 |
CN104447479B (zh) * | 2015-01-13 | 2016-03-23 | 佛山市赛维斯医药科技有限公司 | 含金刚烷和酰胺类衍生物、其制备方法和用途 |
CN104478778B (zh) * | 2015-01-13 | 2016-03-16 | 佛山市赛维斯医药科技有限公司 | 金刚烷酰胺类衍生物、其制备方法和用途 |
CN104496877B (zh) * | 2015-01-13 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一种腈基金刚烷酰胺衍生物、其制备方法和用途 |
CN104529855B (zh) * | 2015-01-13 | 2016-04-13 | 佛山市赛维斯医药科技有限公司 | 一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途 |
CN104447478B (zh) * | 2015-01-13 | 2016-04-13 | 佛山市赛维斯医药科技有限公司 | 一种含腈基金刚烷和酰胺结构的衍生物、其制备方法和用途 |
US10426818B2 (en) | 2015-03-24 | 2019-10-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Method and pharmaceutical composition for use in the treatment of diabetes |
CN114641277B (zh) * | 2019-12-31 | 2023-06-13 | 石药集团中奇制药技术(石家庄)有限公司 | 一种二肽基肽酶4抑制剂的药物组合物及其制备方法和应用 |
WO2021136491A1 (zh) * | 2019-12-31 | 2021-07-08 | 石药集团中奇制药技术(石家庄)有限公司 | 一种二肽基肽酶iv抑制剂的晶型及其制备方法和用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100490807B1 (ko) * | 1995-11-28 | 2005-10-14 | 세파론, 인코포레이티드 | 시스테인및세린프로테아제의d-아미노산함유억제제 |
JP2000264882A (ja) * | 1999-03-18 | 2000-09-26 | Nippon Shokubai Co Ltd | 有機アミド化合物およびその製造方法 |
GB9928330D0 (en) * | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
US6861440B2 (en) | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
CN100430386C (zh) * | 2002-11-07 | 2008-11-05 | 默克公司 | 苯丙氨酸衍生物作为二肽基肽酶抑制剂用于治疗或预防糖尿病 |
ES2278213T3 (es) * | 2002-11-07 | 2007-08-01 | MERCK & CO., INC. | Derivados de fenilamina como inhibidores de la dipeptidilpeptidasa en el tratamiento o la prevencion de la diabetes. |
JP2004203526A (ja) | 2002-12-24 | 2004-07-22 | Sharp Corp | 記録装置 |
US7345180B2 (en) | 2003-01-31 | 2008-03-18 | Sanwa Kagaku Kenkyusho Co., Ltd. | Compound inhibiting dipeptidyl peptidase IV |
US7638638B2 (en) | 2003-05-14 | 2009-12-29 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US20070093492A1 (en) * | 2004-03-09 | 2007-04-26 | Weir-Torn Jiaang | Pyrrolidine derivatives |
AU2005221678B2 (en) * | 2004-03-09 | 2008-10-09 | National Health Research Institutes | Pyrrolidine compounds |
EP1760076A1 (en) * | 2005-09-02 | 2007-03-07 | Ferring B.V. | FAP Inhibitors |
-
2009
- 2009-02-25 NZ NZ587911A patent/NZ587911A/en unknown
- 2009-02-25 WO PCT/US2009/035111 patent/WO2009111239A2/en active Application Filing
- 2009-02-25 EP EP09718154.9A patent/EP2252582B1/en active Active
- 2009-02-25 AU AU2009222198A patent/AU2009222198B2/en active Active
- 2009-02-25 MY MYPI2010004155A patent/MY155630A/en unknown
- 2009-02-25 BR BRPI0906094A patent/BRPI0906094B8/pt active IP Right Grant
- 2009-02-25 CN CN2009801079412A patent/CN101970402B/zh active Active
- 2009-02-25 KR KR1020107021993A patent/KR101634656B1/ko active IP Right Grant
- 2009-02-25 RU RU2010140627/04A patent/RU2494094C2/ru active
- 2009-02-25 ES ES09718154.9T patent/ES2515194T3/es active Active
- 2009-02-25 JP JP2010549729A patent/JP5586484B2/ja active Active
- 2009-02-25 CA CA2717518A patent/CA2717518C/en active Active
- 2009-02-25 US US12/392,590 patent/US8022096B2/en active Active
- 2009-03-03 TW TW098106781A patent/TWI385163B/zh active
-
2010
- 2010-09-03 ZA ZA2010/06329A patent/ZA201006329B/en unknown
-
2011
- 2011-04-04 HK HK11103380.9A patent/HK1149261A1/xx unknown